{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:59:48Z","timestamp":1793969988514,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejpb.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T13:16:50Z","timestamp":1502889410000},"page":"52-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Surface modification of an intraocular lens material by plasma-assisted grafting with 2-hydroxyethyl methacrylate (HEMA), for controlled release of moxifloxacin"],"prefix":"10.1016","volume":"120","author":[{"given":"A. Paula","family":"Vieira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia F.R.","family":"Pimenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Helena","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.G.C.","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5108-4556","authenticated-orcid":false,"given":"Dimitriya","family":"Bozukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago R.","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il\u00eddio J.","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Paula","family":"Serro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Jorge","family":"Guiomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2017.08.006_b0005","first-page":"249","article-title":"Cataract blindness: challenges for the 21st century","volume":"79","author":"Brian","year":"2001","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ejpb.2017.08.006_b0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.15.1.111-124.2002","article-title":"Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions","volume":"15","author":"Callegan","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejpb.2017.08.006_b0015","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.jcrs.2014.10.010","article-title":"Intracameral antibiotics: safety, efficacy, and preparation","volume":"40","author":"Braga-Mele","year":"2014","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ejpb.2017.08.006_b0020","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1586\/eop.10.52","article-title":"Severe bacterial endophthalmitis: towards improving clinical outcomes","volume":"5","author":"Novosad","year":"2010","journal-title":"Expert Rev. Ophthalmol."},{"key":"10.1016\/j.ejpb.2017.08.006_b0025","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.jcrs.2011.06.018","article-title":"Prevention, diagnosis, and management of acute postoperative bacterial endophthalmitis","volume":"37","author":"Packer","year":"2011","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ejpb.2017.08.006_b0030","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jcrs.2013.06.014","article-title":"Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries","volume":"39","author":"Behndig","year":"2013","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ejpb.2017.08.006_b0035","series-title":"ESCRS Guidelines for Prevention and Treatment of Endophthalmitis Following Cataract Surgery: Data","author":"Barry","year":"2013"},{"issue":"2015","key":"10.1016\/j.ejpb.2017.08.006_b0040","first-page":"1300","article-title":"Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the ASCRS member survey","volume":"41","author":"Chang","year":"2014","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ejpb.2017.08.006_b0045","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent perspectives in ocular drug delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.08.006_b0050","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0886-3350(13)80220-9","article-title":"Effect of indomethacin-coated posterior chamber intraocular lenses on postoperative inflammation and posterior capsule opacification","volume":"21","author":"Nishi","year":"1995","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ejpb.2017.08.006_b0055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0886-3350(96)80120-9","article-title":"Inhibition of posterior capsule opacification by an intraocular-lens-bound sustained drug delivery system: an experimental animal study and literature review","volume":"22","author":"Tetz","year":"1996","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ejpb.2017.08.006_b0060","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/02713680601038816","article-title":"Biofilm formation on hydrophilic intraocular lens material","volume":"31","author":"Shimizu","year":"2006","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2017.08.006_b0065","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jcrs.2006.04.033","article-title":"Hydrophilic acrylic intraocular lens as a drug-delivery system for fourth-generation fluoroquinolones","volume":"32","author":"Kleinmann","year":"2006","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ejpb.2017.08.006_b0070","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/02713680802382971","article-title":"Preventive effect against post-cataract endophthalmitis: drug delivery intraocular lens versus intracameral antibiotics","volume":"33","author":"Tsuchiya","year":"2008","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2017.08.006_b0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/jop.2012.0062","article-title":"Hydrophilic acrylic intraocular lens as a drug delivery system: influence of the presoaking time and comparison to intracameral injection","volume":"29","author":"Lipnitzki","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2017.08.006_b0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/ICU.0b013e32835a93fc","article-title":"Intraocular lens as a drug delivery reservoir","volume":"24","author":"Liu","year":"2013","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ejpb.2017.08.006_b0085","unstructured":"EMA (European Medicines Agency, London, UK), EU Clinical Trials Register. http:\/\/www.clinicaltrialsregister.eu, 2016 (accessed 03.05.16)."},{"key":"10.1016\/j.ejpb.2017.08.006_b0090","unstructured":"NLM (National Library of Medicine, Bethesda, MD, USA), ClinicalTrials.gov. http:\/\/clinicaltrials.gov, 2016 (accessed 03.05.16)."},{"key":"10.1016\/j.ejpb.2017.08.006_b0095","unstructured":"UMINC (University Hospital Medical Information Network Center, Tokyo, Japan), UMIN Clinical Trials Registry (UMIN-CTR). http:\/\/www.umin.ac.jp\/ctr\/, 2016 (accessed 03.05.16)."},{"key":"10.1016\/j.ejpb.2017.08.006_b0100","unstructured":"JAPIC (Japan Pharmaceutical Information Center, Tokyo, Japan), JAPIC Clinical Trials Information. http:\/\/www.clinicaltrials.jp\/user\/cteSearch_e.jsp, 2016 (accessed 03.05.16)."},{"key":"10.1016\/j.ejpb.2017.08.006_b0105","unstructured":"JMACCT (Japan Medical Association Center for Clinical Trials, Tokyo, Japan), JMACTR List. https:\/\/dbcentre3.jmacct.med.or.jp\/JMACTR\/Default_Eng.aspx, 2016 (accessed 03.05.16)."},{"key":"10.1016\/j.ejpb.2017.08.006_b0110","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","article-title":"Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors","volume":"33","author":"ESCRS Endophthalmitis Study Group","year":"2007","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ejpb.2017.08.006_b0115","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s12325-008-0107-x","article-title":"Review of third- and fourth-generation fluoroquinolones in ophthalmology: in vitro and in vivo efficacy","volume":"25","author":"Scoper","year":"2008","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejpb.2017.08.006_b0120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcrs.2006.02.021","article-title":"ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study","volume":"32","author":"Barry","year":"2006","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ejpb.2017.08.006_b0125","doi-asserted-by":"crossref","unstructured":"P.A. Asbell, K.A. Colby, S. Deng, P. McDonnell, D.M. Meisler, M.B. Raizman, J.D. Sheppard Jr, D.F. Sahm, Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates, Am. J. Ophthalmol., 145 (2008) 951-958.e951.","DOI":"10.1016\/j.ajo.2008.01.025"},{"key":"10.1016\/j.ejpb.2017.08.006_b0130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09273940600976953","article-title":"In vitro antifungal activity of the fourth generation fluoroquinolones against candida isolates from human ocular infections","volume":"14","author":"Ozdek","year":"2006","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.ejpb.2017.08.006_b0135","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1128\/AAC.48.3.799-803.2004","article-title":"New findings on the structure-phototoxicity relationship and photostability of fluoroquinolones with various substituents at position 1","volume":"48","author":"Hayashi","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2017.08.006_b0140","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1365\/s10337-009-1061-8","article-title":"A validated, specific stability-indicating RP-LC method for moxifloxacin and its related substances","volume":"69","author":"Devi","year":"2009","journal-title":"Chromatographia"},{"key":"10.1016\/j.ejpb.2017.08.006_b0145","first-page":"996","article-title":"Endothelial damage from intraocular lens insertion","volume":"15","author":"Kaufman","year":"1976","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2017.08.006_b0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0146-2776(79)80051-8","article-title":"Surface modification of intraocular lenses to reduce corneal endothelial damage","volume":"5","author":"Knight","year":"1979","journal-title":"Am. Intraocul. Implant Soc. J."},{"key":"10.1016\/j.ejpb.2017.08.006_b0155","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jfo.2009.04.026","article-title":"Implant intraoculaire et chirurgie de la cataracte: comparaison de la adhesion bacterienne et du risque d'endophtalmie selon le biomateriau","volume":"32","author":"Baillif","year":"2009","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.ejpb.2017.08.006_b0160","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1163\/156856193X00556","article-title":"XPS studies of in situ plasma-modified polymer surfaces","volume":"7","author":"Gerenser","year":"1993","journal-title":"J. Adhes. Sci. Technol."},{"key":"10.1016\/j.ejpb.2017.08.006_b0165","first-page":"28","article-title":"Surface treatment, wetting and modulus of silicone hydrogels","volume":"232","author":"Jones","year":"2006","journal-title":"Optician"},{"key":"10.1016\/j.ejpb.2017.08.006_b0170","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/0366-6999.173496","article-title":"Surface modification of intraocular lenses","volume":"129","author":"Huang","year":"2016","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.ejpb.2017.08.006_b0175","unstructured":"C. Pagnoulle, M.A. Robert, M.E. van Steeland, Yellow chromophore agent composition for intraocular lenses and the thus obtainable lenses. Patent WO 2006\/074843 A1, 2006."},{"key":"10.1016\/j.ejpb.2017.08.006_b0180","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s13346-016-0303-1","article-title":"Simulation of the hydrodynamic conditions of the eye to better reproduce the drug release from hydrogel contact lenses: experiments and modeling","volume":"6","author":"Pimenta","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2017.08.006_b0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874364101004010052","article-title":"Aqueous humor dynamics: a review","volume":"4","author":"Goel","year":"2010","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.ejpb.2017.08.006_b0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0166-6622(92)80055-7","article-title":"Computational evaluation of axisymmetric drop shape analysis-profile (ADSA-P)","volume":"62","author":"Cheng","year":"1992","journal-title":"Colloids Surf."},{"key":"10.1016\/j.ejpb.2017.08.006_b0195","unstructured":"ISO (International Organization for Standardization, Geneva, Switzerland), ISO 10993-5: Biological evaluation of medical devices \u2212 Part 5: Tests for in vitro cyto-toxicity, 2009."},{"key":"10.1016\/j.ejpb.2017.08.006_b0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1088\/1748-6041\/2\/4\/006","article-title":"Controlled release gelatin hydrogels and lyophilisates with potential application as ocular inserts","volume":"2","author":"Natu","year":"2007","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.ejpb.2017.08.006_b0205","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/app.35110","article-title":"Effects of argon plasma treatment on surface characteristic of photopolymerization PEGDA\u2013HEMA hydrogels","volume":"124","author":"Tan","year":"2012","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.ejpb.2017.08.006_b0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/jcis.1997.5386","article-title":"Dynamics of polymeric solid surfaces treated with oxygen plasma: effect of aging media after plasma treatment","volume":"202","author":"Murakami","year":"1998","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2017.08.006_b0215","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/ja9831453","article-title":"Probing the surface structural rearrangement of hydrogels by sum-frequency generation spectroscopy","volume":"121","author":"Chen","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2017.08.006_b0220","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1475-1313.1996.95001182.x","article-title":"Effects of tinted intraocular lens on contrast sensitivity","volume":"16","author":"Niwa","year":"1996","journal-title":"Ophthalmic Physiol. Opt."},{"key":"10.1016\/j.ejpb.2017.08.006_b0225","doi-asserted-by":"crossref","unstructured":"J. Shaw, E. F. Smith, R. U. Desai, B. Enriquez and A. Schrier, Can Intraocular Lenses Deliver Antibiotics Intracamerally?, Journal of Ocular Pharmacology and Therapeutics 26((2010) 587-589.","DOI":"10.1089\/jop.2010.0021"},{"key":"10.1016\/j.ejpb.2017.08.006_b0230","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jcrs.2006.01.038","article-title":"Hydrophilic acrylic intralocular lens as a drug-delivery system: pilot study","volume":"32","author":"Kleinmann","year":"2006","journal-title":"J. Cataract Refract. Surger."},{"key":"10.1016\/j.ejpb.2017.08.006_b0235","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/jop.2008.0007","article-title":"Antimicrobial activity of acrylic intraocular lenses soaked in fourth generation fluoroquinolones","volume":"24","author":"Smith","year":"2008","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejpb.2017.08.006_b0240","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcrs.2013.08.062","article-title":"Intraocular concentration of moxifloxacin after intracameral injection combined with presoaked intraocular lenses","volume":"40","author":"Lipnitzki","year":"2014","journal-title":"J. Cataract Refract. Surgery"},{"key":"10.1016\/j.ejpb.2017.08.006_b0245","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/1567201812666150901094810","article-title":"Prevention of staphylococcus epidermidis endophthalmitis by different moxifloxacin prophylaxis routes","volume":"13","author":"Yovel","year":"2016","journal-title":"Current Drug Delivery"},{"key":"10.1016\/j.ejpb.2017.08.006_b0250","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0960-894X(01)81162-8","volume":"1","author":"Barltrop","year":"1991","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116309237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116309237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T09:23:59Z","timestamp":1570008239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116309237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":50,"alternative-id":["S0939641116309237"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.08.006","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surface modification of an intraocular lens material by plasma-assisted grafting with 2-hydroxyethyl methacrylate (HEMA), for controlled release of moxifloxacin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}